BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6110769)

  • 1. Pharmacokinetics of propranolol isomers and their relationships with beta adrenoceptor blocking activity in rabbits administered with dl-propranolol.
    Kawashima K; Ishikawa H
    J Pharmacol Exp Ther; 1980 Jun; 213(3):628-31. PubMed ID: 6110769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific radioimmunoassay for propranolol isomers.
    Kawashima K; Levy A; Spector S
    J Pharmacol Exp Ther; 1976 Feb; 196(2):517-23. PubMed ID: 1255496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of propranolol: a review.
    Shand DG
    Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-effect relationship of l-propranolol and metoprolol in spontaneous hypertensive rats after exercise-induced tachycardia.
    Brynne L; Karlsson MO; Paalzow LK
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1152-8. PubMed ID: 9732372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
    Tachikawa S; Takenaka T; Maeno H
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
    Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
    J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of influence of aluminum hydroxide on the bioavailability and beta-adrenoceptor blocking activity of propranolol.
    Hong CY; Hu SC; Lin SJ; Chiang BN
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):244-6. PubMed ID: 4008113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
    Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
    Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
    Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
    Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of dl- and l-moprolol in the human.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):57-61. PubMed ID: 6120901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of talinolol and the optical isomers of propranolol on LCAT activity in vitro.
    Schauer I; Schauer UJ; Thielmann K
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):608-10. PubMed ID: 6548729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field.
    Soszynski D; Kozak W; Conn CA; Rudolph K; Kluger MJ
    Neuroendocrinology; 1996 May; 63(5):459-67. PubMed ID: 8738584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man.
    Myers MG; Lewis PJ; Reid JL; Dollery CT
    J Pharmacol Exp Ther; 1975 Feb; 192(2):327-35. PubMed ID: 1117420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of plasma kinetics and beta-receptor binding and -blocking activity of timolol following its small intravenous dose.
    Kaila T; Karhuvaara S; Huupponen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):351-7. PubMed ID: 8103764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.